Results 91 to 100 of about 213,070 (226)

Dermatological Disease at a Tertiary Military Hospital in Burundi: A Retrospective Review

open access: yes
International Journal of Dermatology, EarlyView.
Doriane Sabushimike   +5 more
wiley   +1 more source

Acute and Chronic Leukemia in Sub‐Saharan Africa: A Systematic Review

open access: yesCancer Reports, Volume 9, Issue 8, August 2026.
ABSTRACT Background The four primary subgroups of leukemia include chronic myeloid leukemia (CML), acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). Very little is known about the regional variation of leukemia and subtypes in sub‐Saharan Africa (SSA).
Allwell A. Ayirebi   +17 more
wiley   +1 more source

Patient‐ and caregiver‐reported barriers to radiotherapy for cancer in sub‐Saharan Africa—A survey of population‐based registries

open access: yesInternational Journal of Cancer, Volume 159, Issue 3, Page 595-608, 1 August 2026.
What's New? Low‐ and middle‐income countries have over 70% of the global cancer burden but 10% of the world's radiotherapy capacities. This population‐based multi‐country study explores the barriers to access experienced by cancer patients in sub‐Saharan Africa.
Eric Sven Kroeber   +21 more
wiley   +1 more source

Kaposi’s sarcoma: a 10-year experience with 248 patients at a single tertiary care hospital in Tanzania

open access: yesBMC Research Notes, 2015
Kaposi’s Sarcoma is the most common sarcoma and second most prevalent cancer seen in Tanzania. Little is known about Kaposi’s sarcoma in our setting as there is paucity of recent published data regarding this condition.
P. Chalya   +7 more
semanticscholar   +1 more source

SARS‐CoV‐2 mRNA Vaccination Induces Neutralizing Antibodies and Type I IFN Changes in People Living With HIV

open access: yesJournal of Medical Virology, Volume 98, Issue 8, August 2026.
ABSTRACT This study examined changes in anti‐Spike (anti‐S) antibodies (Abs) and type I interferon (IFN‐I) following the BNT162b2 vaccine in people living with HIV (PLWH) and analyzed the impact of demographic and immunological factors. In total, 75 PLWH and 28 healthy donors were followed at baseline (T0), at the second dose (T1), after the second ...
Federica Frasca   +18 more
wiley   +1 more source

Kaposi's sarcoma [PDF]

open access: yesCancer, 1959
F H, COX, E B, HELWIG
openaire   +2 more sources

Sarcoma de Kaposi en paciente con diagnóstico tardío de VIH. Presentación de un caso y revisión.

open access: yesRevista de la Facultad de Ciencias Médicas de Córdoba, 2017
El sarcoma de Kaposi es un tumor linfoangioproliferativo descripto por primera vez en el año 1872 por Moritz Kaposi. Hay cuatro variantes clínicas, la forma clásica, la endémica, la iatrogénica asociada a trasplante o inmunosupresión y la epidémica ...
María Belén Castaño   +4 more
doaj   +1 more source

Lysine l‐Lactylation: Bridging Metabolism, Chromatin and Disease

open access: yesCell Proliferation, Volume 59, Issue 8, August 2026.
Enzymatic regulation of KL‐la. The enzymatic regulation of KL‐la involves two distinct pathways for L‐lactate accumulation: intracellular production through glycolysis‐derived pyruvate conversion by lactate dehydrogenase (LDH) or direct cellular uptake via monocarboxylate transporters (MCTs). These L‐lactate pools fuel two distinct lactylation pathways—
Anoosha Malik   +10 more
wiley   +1 more source

Absence of DNA viruses in ameloblastomas

open access: yesEuropean Journal of Oral Sciences, Volume 134, Issue 4, August 2026.
Abstract Ameloblastomas (ABs) are rare odontogenic benign tumors. Although studies of the molecular pathogenesis have revealed the presence of mutations and altered gene expression, the etiology is unresolved. Viruses cause 10%–15 % of cancers, but their potential role within benign tumors is less studied.
Maria K. Jauhiainen   +5 more
wiley   +1 more source

Painful Purplish Lesion on the Right Lower Lip Mucosa

open access: yes
Oral Diseases, EarlyView.
Isabella Cristine Pegolo Dos Santos Alamino   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy